BioAsia 2024 to discuss "Data and AI" to reshape future of life sciences

BioAsia, the annual event dedicated to the life sciences sector, is gearing up to set a new standard with its 21st edition, BioAsia 2024, scheduled from February 26 to 28, 2024.

This transformative event, held under the overarching theme of "Data and AI: Redefining Possibilities," is poised to reshape the future of life sciences.BioAsia 2024 is set to welcome a galaxy of visionary keynote speakers.

Dave Ricks, CEO of Eli Lilly- A titan in the life sciences realm, Dave Ricks leads one of the world's most esteemed pharmaceutical giants. 

Under his leadership, the market valuation of Eli Lilly has skyrocketed from around USD 80 billion in 2017 to USD 310 billion in 2023.

Dr Chris Boerner, Incoming CEO of Bristol Myers Squibb (BMS)- A distinguished figure in the pharmaceutical industry, Dr Chris Boerner is set to lead Bristol-Myers Squibb into the future. 

BMS stands as one of the world's largest pharmaceutical companies, consistently ranking on the Fortune 500 list of the largest US corporations.Geoff Martha, Chairman and CEO, Medtronic- Geoff Martha, a visionary leader, is steering Medtronic towards groundbreaking innovations. 

He leads a USD 32 billion company with 95,000 employees, delivering pioneering technology solutions to more people worldwide.

Christophe Weber, CEO of Takeda - With a wealth of global pharmaceutical expertise, Christophe Weber brings his leadership experience to the BioAsia platform. 

His strategic leadership spearheaded Takeda's USD 62 billion acquisition of Shire, expanding Takeda's global presence and strengthening its rare disease and gastroenterology portfolios.

Nobel Laureate Professor Gregg Semenza- Professor Gregg Semenza, a Nobel laureate in Physiology or Medicine in 2019, is celebrated for his groundbreaking work on oxygen sensing. 

His discovery of the Hypoxia-Inducible Factor 1 (HIF) pathway has not only advanced our understanding of conditions like cancer and anaemia but has also paved the way for innovative therapies.

This luminary lineup of keynote speakers spans the breadth of life sciences expertise, making BioAsia 2024 an unparalleled platform for networking and knowledge sharing.

Minister KT Rama Rao, Minister for Industries and Commerce, IT, Electronics and Communications, Government of Telangana, emphasized the global prominence of BioAsia, reflecting Telangana's unwavering commitment to innovation and research.

Shakthi M Nagappan, CEO of Telangana Lifesciences and BioAsia, Government of Telangana, underscored the event's growing global influence, anticipating the addition of even more influential leaders to this already impressive lineup.

Principal Secretary Industries and Commerce (I&C) Jayesh Ranjan praised BioAsia for bringing together the finest minds in the life sciences domain and for its pivotal role in shaping the life sciences landscape.

BioAsia 2024 is organized in partnership with EY India as the Knowledge Partner. 

This collaboration aims to foster transformative ideas and partnerships, further elevating BioAsia's status as a global event.

BioAsia has earned global recognition as a premier life sciences event, and the presence of these eminent leaders underscores Telangana's position as a life sciences powerhouse. 

BioAsia 2024 is poised to be a milestone event, pushing the boundaries of life sciences and healthcare into uncharted territories. With its focus on data, AI, and life sciences, BioAsia 2024 promises to redefine the future of healthcare and research.

BioAsia is the leading life sciences and healthcare forum in Asia, serving as a pivotal platform for thought leaders, industry pioneers, and policymakers to explore and showcase breakthroughs in life sciences and healthcare.

With its vibrant ecosystem, BioAsia fosters collaborations, discussions, and partnerships that drive innovation and shape the future of the industry.